The International Neuroblastoma Risk Group (INRG) defined 16 different patient risk categories based on the INRG stage, tumor histology, and grade of tumor differentiation, MYCN status, 11q status, ploidy, and anaplastic lymphoma kinase amplification [8]. Here, MYCN is linked to neoplasm.